相关实验视频

Updated: Sep 19, 2025

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

Published on: May 31, 2020

通过向淋巴结中的巨细胞的Irg1来提高mRNA癌症疫苗的疗效

Wenwen Wei^1,2,3, Xiao Yang^1,2,3, Yeshan Chen^1,2,3

¹Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

|June 16, 2025

概括

通过免疫反应基因1 (Irg1) 敲除向巨细胞中伊塔康酸盐的生产,可以提高mRNA癌症疫苗的疗效. 削弱Irg1可以改善T细胞功能,提高治疗效果,为癌症免疫疗法提供了一种新的策略.

科学领域:

免疫学免疫学免疫学
癌症治疗癌症治疗
代谢学代谢学代谢学

背景情况:

使者RNA (mRNA) 癌症疫苗具有显著的治疗潜力,但在有效性方面存在局限性.
代谢物对免疫系统调节至关重要,但它们在mRNA癌症疫苗中的特定作用尚不清楚.

研究的目的:

研究代谢物在mRNA癌症疫苗治疗中的作用.
确定影响疫苗疗效的关键代谢物及其细胞来源.
探索提高mRNA癌症疫苗性能的策略.

主要方法:

用代谢组分析和单细胞RNA测序来确定关键代谢物及其来源.
实验涉及B16-F10-OVA瘤携带的小鼠,有或没有Irg1枯竭,接受了卵蛋白编码mRNA-脂质纳米粒子 (OVA-LNP) 和/或抗PD-1抗体的治疗.
流细胞计用于分析淋巴结,脏和瘤微环境中的免疫细胞群.

主要成果:

在OVA-LNP注射后,巨衍生的伊塔康酸水平在淋巴结中增加.
在巨细胞中免疫反应基因1 (Irg1) 的衰竭增强了树突细胞抗原呈现和T细胞功能.
在LNP中将Irg1敲击与OVAmRNA结合起来,提高了mRNA癌症疫苗作为单疗法和抗PD-1抗体的疗效.

结论:

伊塔科纳酸与mRNA癌症疫苗的疗效有关.
使用小干扰RNA (siRNA) -LNP准Irg1代表了增强mRNA癌症疫苗治疗效果的有希望的策略.

关键词:

这里是DCs DCs DCs.反PD-1 抗体的抗体.在mRNA癌症疫苗的使用中.巨细胞是什么?巨细胞是什么?塔科纳酸是一种酸盐.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...